High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype

A prospective analysis of cytomegalovirus (CMV) glycoprotein B (gB) genotypes was conducted on 34 renal transplant recipients using peripheral blood leukocytes (PBLs) and urine specimens. The CMV gB genotypes were analyzed by polymerase chain reaction (PCR) followed by enzyme digestion. PBLs and urine samples showed almost equal proportions of the 4 known gB genotypes, as well as equal proportions of gB genotype mixtures. The gB genotypes 1, 2 and 3 were equally distributed in the patients. Twenty‐four (70.6%) patients had more than one gB genotype during follow‐up. There was no association of gB genotypes with the development of symptomatic CMV infection. J. Med. Virol. 61:138–142, 2000. © 2000 Wiley‐Liss, Inc.

[1]  F. Hufert,et al.  High variability of cytomegalovirus glycoprotein B gene and frequent multiple infections in HIV-infected patients with low CD4 T-cell count. , 1998, AIDS (London).

[2]  F. Verbraak,et al.  Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. , 1998, Investigative ophthalmology & visual science.

[3]  F. Hufert,et al.  Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection , 1998, Journal of medical virology.

[4]  G. Duarte,et al.  Congenital and perinatal cytomegalovirus infection in infants born to mothers infected with human immunodeficiency virus. , 1998, The Journal of pediatrics.

[5]  O. Weiland,et al.  GBV‐C/HGV infection in hepatitis C virus‐infected deferred Swedish blood donors , 1998, Journal of medical virology.

[6]  K. Yuen,et al.  Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease , 1997, Clinical and diagnostic laboratory immunology.

[7]  W. Leisenring,et al.  Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. , 1997, Blood.

[8]  C. Payá,et al.  Infections in solid-organ transplant recipients , 1997, Clinical microbiology reviews.

[9]  F. Hufert,et al.  Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients , 1996, Journal of medical virology.

[10]  S. Lipson,et al.  Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. , 1996, The Journal of infectious diseases.

[11]  E. Mocarski,et al.  Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. , 1995, The Journal of infectious diseases.

[12]  M. Boeckh,et al.  Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.

[13]  P. Paz,et al.  Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. , 1993, Virology.

[14]  S. Chou,et al.  Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. , 1991, The Journal of infectious diseases.

[15]  M. van der Giessen,et al.  Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. , 1989, Transplantation.

[16]  J. van Lunzen,et al.  Glycoprotein B genotype of human cytomegalovirus: distribution in HIV-infected patients. , 1996, Scandinavian journal of infectious diseases.